Although the most immediately threatening symptoms of COVID-19 are respiratory, neuroscientists are intently studying the pandemic from the perspective of the central nervous system. Clinical research and case reports provide ...
Apr 29, 2020
0
490
Drug companies sponsoring human trials of possible new medications have ethical responsibilities to study participants and to science to disclose the results of their clinical research -- even when product development is ...
Sep 28, 2011
1
0
A new combination of immunotherapy and chemotherapy for pancreatic cancer caused tumors to shrink in the majority of evaluable patients—20 out of 24 as of an interim analysis of the phase 1b trial data. The early findings ...
Mar 31, 2019
2
185
A research team led by Prof. Stephan Ludwig, a virologist at the Institute of Virology at the University of Münster, has found a new dual attack mode of action while working on the development of a drug candidate against ...
Jan 14, 2022
0
201
Vaccinated people who were infected by the first omicron subvariants have four times greater protection than vaccinated people who were not infected. These results are part of a study that will be published today in the New ...
Sep 1, 2022
6
111
A small study offers the first hint that an extra dose of COVID-19 vaccines just might give some organ transplant recipients a needed boost in protection.
Jun 15, 2021
0
1
A breast cancer vaccine already shown to elicit a powerful immune response in women with varying levels of HER2 expression has the ability to improve recurrence rates and is well tolerated in an adjuvant setting, according ...
May 17, 2012
0
0
A team from UNSW's Kirby Institute and St Vincent's Hospital Sydney have uncovered an immune profile for long COVID, potentially paving the way for tailored treatment for those with ongoing symptoms.
Jan 14, 2022
1
190
Even before carbohydrates reach the bloodstream, the very sight and smell of a meal trigger the release of insulin. For the first time, researchers from the University of Basel and University Hospital Basel have shown that ...
Jun 30, 2022
0
161
The induction of neutralizing antibodies by a prophylactic Chikungunya vaccine candidate has now been confirmed by the final results of a phase 1 clinical trial, as well as its tolerability and safety. Detailed information ...
Nov 20, 2014
0
0
